MOZI TPS

by Manteia Technologies Co., Ltd.  · Based in China →The New Treatment Planning System
Oncology

Contact for pricing
Regulatory Status Disclosed

Overview

MOZI TPS (MOZI Treatment Planning System) is a next-generation AI-powered software solution designed for radiation oncology. It combines precision, speed, and adaptability for radiotherapy treatment planning. The system features a Monte Carlo Dose Engine for high-precision dosing, GPU-powered computation for fast processing, and vendor independence, supporting multiple accelerator types. MOZI TPS offers seamless automation, including AI-driven automated contouring and planning, and revolutionary on-line adaptive planning for real-time adaptation to patient anatomical changes. It supports various treatment techniques such as 3D-CRT, IMRT, VMAT, SBRT, and CBCT/MRI-guided on-line adaptation. Its core functions encompass image processing, structure delineation, plan design, optimization, and evaluation for patients with malignant or benign diseases requiring external beam irradiation with photon beams.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Monte Carlo Dose Engine
  • GPU-powered Computation
  • Vendor Independence (supports multiple accelerator types)
  • Seamless Automation (automated contouring and planning)
  • Revolutionary On-line Adaptive Planning (real-time adaptation)
  • Multi-Scenario Support (3DCRT, IMRT, VMAT, SBRT, On-line Adaptive)
  • Deep Learning based Auto-Planning
  • Image Processing
  • Structure Delineation
  • Plan Design, Optimization, and Evaluation

Use Cases

  • Radiotherapy treatment planning for malignant diseases
  • Radiotherapy treatment planning for benign diseases
  • External beam irradiation with photon beams
  • On-line Adaptive Radiation Therapy (ART) workflow
  • Automated contouring of anatomical structures
  • Dose calculation and optimization

What Physicians Need to Know

Evidence Base
MOZI TPS is backed by robust research and clinical evidence. Its auto-contouring and auto-planning models are guide-line based and validated on standard protocols. The system's deep learning models are validated and released with new system updates.
Clinical Validation Studies
The system has undergone extensive testing for performance and safety, with algorithms for dose calculation, deformable registration, and structure delineation validated against recognized standards and predicate devices, demonstrating non-inferiority. Comprehensive performance testing included software validation, Monte Carlo dose calculation accuracy, and segmentation performance. It is validated and practiced in daily clinical workflow by over 1200 worldwide centers.
Guideline Update Frequency
Deep learning models within MOZI TPS are validated and released with new system updates, based on standard treatment protocols. Additionally, users can adapt and optimize these models based on their own protocols and clinical cases through the integrated AccuLearning module.
Clinical Workflow Integration
MOZI TPS is designed for seamless end-to-end on-line adaptive radiation therapy (ART) workflows, combining image processing, auto-contouring, re-planning, QA, and treatment delivery within minutes. It is a vendor-independent, fully interoperable system that integrates into existing workflows, enhancing treatment accuracy and adaptability. It automates contouring and planning, boosting efficiency by over 90%.
Decision Audit Trail
Specific details about a 'Decision Audit Trail' feature within MOZI TPS were not explicitly found in the provided search results. General concepts of decision audit trails involve logging and tracking agent-made decisions with confidence scores and supporting evidence.
Physician Tip

Leverage MOZI TPS for its advanced AI-driven automation in contouring and planning to significantly reduce manual workload and improve efficiency in radiation therapy. Utilize its real-time adaptive planning capabilities for personalized patient care, especially for cases with anatomical changes. Explore the AccuLearning module to customize deep learning models to your specific clinical protocols and patient populations, ensuring the system aligns with your institutional standards and evolving needs. While the system excels in treatment planning, remember that it is a specialized tool for radiation oncology and does not provide general diagnostic or drug interaction support.

MOZI TPS is designed for vendor independence, supporting multiple accelerator types and seamlessly integrating into existing clinical workflows. Its interoperability allows for comprehensive radiation therapy solutions, including image-based treatment planning, QA/QC, and Adaptive Radiation Therapy (ART), with AI and Monte Carlo integration. It supports various imaging modalities like CT, MRI, and PET-CT for accurate multimodal alignment and plan review across different TPS systems.

Details

Category Oncology AI, Surgical AI
Pricing Contact for pricing
DeploymentStandalone software
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

MOZI TPS is a Class II medical device under regulation 21 CFR 892.5050, cleared by the U.S. FDA via 510(k) premarket notification (K223724) on July 10, 2023. It is indicated for planning radiotherapy treatments for patients with malignant or benign diseases using external beam irradiation with photon beams.

Integrations
EHR Not specified
Specialties Oncology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate MOZI TPS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for MOZI TPS.

View all on YouTube

Frequently Asked Questions

MOZI TPS is designed for seamless integration into the radiation oncology workflow, automating image processing, auto-contouring, re-planning, and quality assurance within minutes. It leverages deep learning for highly automated dose optimization, accurate structure delineation, and real-time adaptive radiotherapy, supporting various techniques including 3DCRT, IMRT, VMAT, SBRT, and on-line adaptive planning with both CBCT and MR images.
MOZI TPS is approved by the U.S. FDA as a Class II medical device under regulation 21 CFR 892.5050, ensuring it meets stringent safety and effectiveness standards. While specific HIPAA compliance details for MOZI TPS are not explicitly stated, medical devices in the US must adhere to data privacy regulations, and the broader life sciences industry emphasizes 'privacy by design' and safeguards like de-identification for sensitive data.
Key limitations of MOZI TPS include its dependence on accurate input data and the necessity for skilled operation by trained medical professionals. Challenges also involve ensuring system compatibility with various imaging devices and navigating the inherent complexities of adapting AI and machine learning algorithms to diverse and intricate clinical scenarios.
Yes, MOZI TPS offers customization capabilities. While its deep learning models are validated on standard protocols, they can be adapted by users to align with their institution's specific protocols and clinical cases through the integrated AccuLearning module. AccuLearning facilitates personalized and interactive training of these deep learning models.
MOZI TPS distinguishes itself through its exceptional level of automation, speed, and unique ability to facilitate ON-LINE Adaptive Radiation Therapy for all treatment fractions, including integration with MR-Linac. It offers vendor independence, supporting multiple accelerator types, and aims to streamline the entire workflow from imaging to plan delivery within minutes.
MOZI TPS significantly boosts clinical efficiency by automating time-consuming tasks like contouring and planning, drastically reducing plan generation time. It enables real-time adaptive planning, allowing for immediate adjustments based on daily anatomical changes, thereby personalizing treatment for each patient and safely supporting hypofractionated protocols.
While specific training programs for MOZI TPS are not fully detailed in the provided information, Manteia Technologies and its distributors typically offer comprehensive training and ongoing support for such advanced medical devices. The integrated AccuLearning module also provides a platform for personalized training of deep learning models, implying user education for effective customization and operation.

Related Tools

FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
eyonis® LCS
Median Technologies
Oncology AI
eyonis® LCS is an FDA 510(k) cleared AI/machine learning-powered software for the detection and diagnosis of lung cancer, helping clinicians detect and characterize suspicious parenchymal pulmonary nodules earlier on low-dose CT scans.
Lumea Digital Pathology
Lumea
Clinical Decision Support & Reference
Lumea is a specialty-specific digital pathology platform that covers the entire diagnostic workflow, from biopsy to final report, and integrates AI tools from partners like Paige and Mindpeak.
Azra AI
Azra AI
Clinical Decision Support & Reference
Azra AI is an AI platform that swiftly analyzes, identifies, and classifies cancer patients, triaging those needing therapy and follow-up to enhance oncology care. It is deployed at more than 1,500 sites and integrated with leading EHRs.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.

See all Oncology AI tools →

More from Manteia Technologies Co.

AccuContour
Manteia Technologies Co., Ltd.
Oncology AI
AccuContour by Manteia Technologies is an AI-driven auto-contouring solution for radiation oncology, enhancing efficiency and precision in treatment planning through automated OAR and tumor target contouring, image fusion, plan review, and dose accumulation.
ARTAssistant
Manteia Technologies Co., Ltd.
Oncology AI
ARTAssistant by Manteia Technologies Co., Ltd. is an FDA-cleared AI-powered software for adaptive radiation therapy, focusing on image processing, registration, and contouring to enhance precision and efficiency in cancer treatment.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.